fbpx

Artitis

MedWorm.com provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Arthritis
  1. Psoriatic arthritis diagnosis by a rheumatologist within a year of symptom onset improved long-term clinical outcomes, a study showed.Medscape Medical News (Source: Medscape Rheumatology Headlines)

    MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

  2. THURSDAY, March 14, 2024 -- The overall number of clinically active rheumatology providers grew more than 20 percent during the last decade, according to a study published online Feb. 25 in Arthritis& Rheumatology.Melissa L. Mannion,... (Source: Drugs.com - Pharma News)
  3. On Sunday, MoonLake Immunotherapeutics MLTX announced that continued treatment with Nanobody sonelokimab led to significant improvements across all key outcomes at 24-week data from the ARGO trial in psoriatic arthritis (PsA). The 207-patient ARGO trial demonstrated that the primary endpoint, the…#pasi #abbvieincs #abbvhumira #acr50pasi100 #acr #mda #tnf #moonlake (Source: Reuters: Health)
  4. (Source: FDA Center for Drug Evaluation and Research - What's New)
  5. (Source: FDA Center for Drug Evaluation and Research - What's New)
  6. (MedPage Today) -- Rates of new-onset autoimmune inflammatory rheumatic disease (AIRD) such as rheumatoid arthritis and systemic lupus erythematosus were significantly increased following bouts of COVID-19 in South Korea and Japan, researchers... (Source: MedPage Today Infectious Disease)

    MedWorm Message:

  7. The expert advised cutting out some popular foods from your diet that are known to worsen inflammation. (Source: Daily Express - Health)
  8. FRIDAY, March 1, 2024 -- The age-adjusted prevalence of adults with arthritis was 18.9 percent in 2022 in the United States, according to a February data brief published by the National Center for Health Statistics. Nazik Elgaddal, from the... (Source: Drugs.com - Pharma News)
  9. FRIDAY, March 1, 2024 -- Once considered harmless by doctors, calcium crystal deposits in the knee joint actually can contribute to worsening arthritis, a new study warns.CT scans have revealed that calcium crystals in the knee can promote joint... (Source: Drugs.com - Daily MedNews)
  10. Imaging elderly patients presents unique challenges, but radiologists can be proactive in making procedures for this population easier, according to a talk given at ECR 2024. In his presentation, Uffe LW Jakobsen from UCL University College in Odense, Denmark, outlined strategies for radiologists to better communicate with elderly patients by treating them like any other patient and forming relationships with them. “Only then can communicate and conduct an examination where we take the appropriate considerations into account without depriving them of their independence and without compromising image quality,” Jakobsen said. Medical professionals may fall into a tendency to “talk down” toward elderly patients, a phenomenon called elderspeak. Elderspeak is characterized by slow, c...
  11. Serious health issues such as diabetes, arthritis and heart defects could be detected in the hands. (Source: Daily Express - Health)

    MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

  12. Leukotriene-induced T cell pyroptosis drives synovial inflammation in rheumatoid arthritis. (Source: Signal Transduction Knowledge Environment)
  13. Friday, Alvotech ALVO and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd TEVA, announced the FDA approved Simlandi (adalimumab-ryvk) injection, as an interchangeable biosimilar to AbbVie Inc’s ABBV Humira. The biosimilar is indicated for adult rheumatoid arthritis,…#alvotech #tevapharmaceuticals #fda #abbvieincs #abbvhumira #crohn #humira #teva #tevapharma #splitspeculations (Source: Reuters: Health)
  14. A woman's painful arthritis symptoms were made better after just one box of the supplement. (Source: Daily Express - Health)
  15. Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reactionThe U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergiesAllergic reactions can be life-threatening and it is estimated that food-related anaphylaxis results in 30,000 medical events treated in emergency rooms in the U.S. each year1-3Basel, 25 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from Stage 1 of the National Institutes of Health (NIH)-sponsored pivotal Phase III OUtMATCH study evaluating the efficacy and safety of Xolair® (omalizumab) in patients allergic to peanuts...
  16. FRIDAY, Feb. 23, 2024 -- Therapeutic intervention with abatacept is feasible for patients at risk for rheumatoid arthritis, according to a study published online Feb. 13 in The Lancet. Andrew P. Cope, M.D., from King's College London, and... (Source: Drugs.com - Pharma News)
  17. This tasty spice is also thought to have anti-inflammatory properties that could help arthritis patients. (Source: Daily Express - Health)
  18. (MedPage Today) -- Inflammatory markers were reduced in patients with persistent joint pain and other markers for incipient rheumatoid arthritis (RA), as was progression to formal RA diagnosis, after a 6-month course of abatacept (Orencia) in a... (Source: MedPage Today Rheumatology)
  19. Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2   Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16  February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Xolair® (omalizumab) for the reduction of allergic reactions, including anaphylaxis, that may occur with accidental exposure t...
  20. FRIDAY, Feb. 16, 2024 -- For patients with rheumatoid arthritis (RA), the risk for ischemic stroke is lower for those receiving acupuncture, according to a study published online Feb. 13 in BMJ Open. Chia-Yu Huang, from Taichung Tzu Chi Hospital in... (Source: Drugs.com - Pharma News)

Izdvojene vijesti

Pratite nas

Newsletter

Prijavite se na naš Newsletter!